Research News

---

Topic: Diagnosis (view all topics)

Tags for topic Diagnosis:

• 1cm-1.9cm
• Ductal Carcinoma In Situ
• Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ)
• Early-stage: Stage IA
• Early-stage: Stage IB
• Early-stage: Stage IIA
• Early-stage: Stage IIB
• Early-stage: Stage IIIA
• Estrogen Receptor Negative Cancer
• Estrogen Receptor Positive Cancer
• HER2/neu Negative Cancer
• HER2/neu Positive Cancer
• HER2 Overexpressing
• Invasive or Infiltrating Ductal Carcinoma
• Invasive or Infiltrating Lobular Carcinoma
• Less than 1cm
• Locally Advanced-stage: Stage IIIB
• Locally Advanced-stage: Stage IIIC
• Luminal A
• Luminal B
• Metastatic
• Metastatic/Advanced-stage: Stage IV
• Non-Metastatic
• Progesterone Receptor Negative Cancer
• Progesterone Receptor Positive Cancer
• Regional
• Triple Negative

View articles by month and year

• Micrometastases in Lymph Nodes Need Treatment

  Published on June 4, 2009 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  When small groups of breast cancer cells are found in the sentinel lymph node during surgery to remove early-stage breast cancer, they need to be treated to reduce the risk of the cancer coming back.

• New Tool Can Help Predict Recurrence Risk

  Published on September 24, 2008 at 12:00 am

  • Tags: Non-Metastatic, Progesterone Receptor Positive Cancer, Estrogen Receptor Positive Cancer, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  A new tool that looks at four breast cancer characteristics seems to do a good job of predicting whether early-stage hormone-receptor-positive breast cancer is likely to come back (recurrence). The tool assessed recurrence in women diagnosed with early-stage hormone-receptor-positive breast cancer that had been treated with hormonal therapy before surgery.

• MRI Before Treatment Doesn’t Improve Care or Prognosis

  Published on September 8, 2008 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, and Breast MRI

  Routinely doing MRI after diagnosis and before surgery may lead to more mastectomy recommendations vs. lumpectomy recommendations with no improvement in care or outcome.

• Breast Cancer Detected by MRI More Likely to be Treated with Mastectomy

  Published on May 16, 2008 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Breast MRI, and Mammography

  When breast cancer is diagnosed by MRI, women are more likely to have a mastectomy than a lumpectomy followed by radiation therapy.

• Women More Likely to Die from Cause Other Than Breast Cancer

  Published on February 12, 2008 at 12:00 am

  • Tags: Progesterone Receptor Positive Cancer, Estrogen Receptor Positive Cancer, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, and Early-stage: Stage IIIA

  Older women with hormone-receptor-positive early breast cancer are more likely to die from something other than breast cancer.

• Gaining Weight After Diagnosis Decreases Survival

  Published on December 11, 2007 at 12:00 am

  • Tags: Metastatic, Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, and Obesity

  Women who gain weight after being diagnosed with breast cancer have a worse prognosis than women who don't gain weight.

• Recurrence After Lumpectomy Higher in African American Woman Than Whites

  Published on November 1, 2007 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Lumpectomy, Mastectomy, and Planning Surgery

  A new study adds to research saying that lumpectomy plus radiation therapy is a good option for African American women with early breast cancer.

• Measuring Circulating Tumor Cells May Help Determine Recurrence Risk

  Published on September 24, 2007 at 12:00 am

  • Tags: Non-Metastatic, Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, and Blood Marker Tests

  A test that measures circulating tumor cells in the blood may help doctors more accurately determine the risk of breast cancer recurrence.

• Women with Abnormal BRCA1 Gene Have Worse Prognosis Than Women with Abnormal BRCA2 Gene

  Published on September 7, 2007 at 12:00 am

  • Tags: Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, and Genetics (including BRCA)

  A new study suggests that having an abnormal BRCA2 gene has a better prognosis 5 years after diagnosis than having an abnormal BRCA1 gene.

• Low Fat Diet Doesn’t Affect Survival or Recurrence

  Published on July 17, 2007 at 12:00 am

  • Tags: Early-stage: Stage 0 -- DCIS (Ductal Carcinoma in Situ), Early-stage: Stage IA, Early-stage: Stage IB, Early-stage: Stage IIA, Early-stage: Stage IIB, Early-stage: Stage IIIA, Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, Nutrition, and Diet

  Results from the WHEL trial show that a low-fat diet that is rich in fruits, vegetables and fiber appears to have no effect on survival or cancer recurrence.